Issuance of New Shares and Stock Acquisition Rights through a Private Placement
First written in FY2017-Q1. 25 of 26 entries say "Advanced", first in FY2017-Q2. Latest entry: FY2026.
The whole theme swung hardest in 2025: 1 of 6 companies on the "Worse" side.
3 other companies' latest entry also says "Advanced".
- FY2026AdvancedAnnual report
「Of the funds raised through this financing, ¥9.5 billion was allocated to the acquisition of bitcoin. As of 31 March 2026, the total acquisition cost of cryptoassets was ¥22.9 billion.」
The company raised a total of ¥10.7 billion through stock acquisition rights and privately placed bonds allocated to EVO FUND, of which ¥9.5 billion was allocated to the acquisition of bitcoin. - FY2026-H1AdvancedAnnual report
「The company issued stock acquisition rights with an exercise-price adjustment clause through a third-party allotment to EVO FUND and unsecured bonds offered by private placement (the “Financing”), raising a total of ¥10.2 billion by 30 September 2025.」
The company raised funds through the Twenty-Fourth and Twenty-Fifth Series Stock Acquisition Rights and unsecured bonds, raising a total of ¥10.2 billion by 30 September 2025. - FY2023-Q2AdvancedAnnual report
「During the six months ended in the second quarter, new shares were issued through the partial exercise of paid stock options, in the form of the Eleventh, Fourteenth, Seventeenth and Nineteenth Series Stock Acquisition Rights, issued to the company's directors, employees and others. As a result, capital and the capital reserve each increased by ¥693 million.」
The partial exercise of the Eleventh, Fourteenth, Seventeenth and Nineteenth Series Stock Acquisition Rights led to the issuance of new shares and increased capital and the capital reserve by ¥693 million each. - FY2023-Q1AdvancedAnnual report
「The exercise of the Eleventh, Fourteenth, Seventeenth and Nineteenth Series Stock Acquisition Rights increased the total number of issued shares by 6,127,600 and increased capital and the capital reserve by ¥686 million each.」
The exercise of multiple series of stock acquisition rights resulted in the issuance of 6,127,600 shares during the quarter and increased capital and the capital reserve by ¥686 million each. - FY2022AdvancedAnnual report
「1 April 2021–31 March 2022 (Note 1) 18,276,700 116,530,700 1,371 7,180 1,371 7,198」
The exercise of stock acquisition rights resulted in the issuance of 18,276,700 shares during the year and increased capital and the capital reserve by ¥1,371 million each. - FY2022-Q3AdvancedAnnual report
「During the nine months ended in the third quarter, new shares were issued following the exercise by リバイブ投資事業組合, the allottee of the Fifteenth, Sixteenth and Eighteenth Series Stock Acquisition Rights. As a result, capital and the capital reserve each increased by ¥1,321 million.」
In addition to the Fifteenth and Sixteenth Series Stock Acquisition Rights, exercise of the Eighteenth Series progressed, increasing capital and the capital reserve by ¥1,321 million each. The Eighteenth Series Stock Acquisition Rights resulted in the delivery of 10,309,300 shares and raised ¥1,558 million. - FY2022-Q2AdvancedAnnual report
「During the six months ended in the second quarter, new shares were issued following the exercise by リバイブ投資事業組合, the allottee of the Fifteenth and Sixteenth Series Stock Acquisition Rights. As a result, capital and the capital reserve each increased by ¥531 million.」
The exercise of the Fifteenth and Sixteenth Series Stock Acquisition Rights led to the issuance of new shares and increases in capital and the capital reserve, and the financing continued. - FY2022-Q1AdvancedAnnual report
「During the first quarter, new shares were issued following the partial exercise by リバイブ投資事業組合, the allottee of the Fifteenth Series Stock Acquisition Rights. As a result, capital and the capital reserve each increased by ¥155 million.」
The partial exercise of the Fifteenth Series Stock Acquisition Rights resulted in the issuance of new shares, increasing capital and the capital reserve by ¥155 million each. - FY2021AdvancedAnnual report
「1 April 2020–31 March 2021 (Note 1) 37,336,400 98,254,000 1,722 5,808 1,722 5,826」
During the fiscal year, 37,336,400 shares were issued through the exercise of stock acquisition rights, increasing capital and the capital reserve by ¥1,722 million each. - FY2021-Q3AdvancedAnnual report
「During the nine months ended in the third quarter, new shares were issued following the partial exercise by リバイブ投資事業組合, the allottee of the Thirteenth Series Stock Acquisition Rights. As a result, capital and the capital reserve each increased by ¥1,158 million.」
The partial exercise of the Thirteenth Series Stock Acquisition Rights increased capital and the capital reserve by ¥1,158 million each. A total of 4,770,100 shares were issued in the third quarter alone, advancing the financing. - FY2021-Q2AdvancedAnnual report
「The exercise of the Thirteenth Series Stock Acquisition Rights increased the total number of issued shares by 11,879,100 and increased capital and the capital reserve by ¥504 million each.」
During the six months ended in the second quarter, the Thirteenth Series Stock Acquisition Rights were exercised, resulting in the issuance of 11,879,100 shares and increasing capital and the capital reserve by ¥504 million each. - FY2021-Q1AdvancedAnnual report
「During the first quarter, stock acquisition rights related to bonds with stock acquisition rights subject to an exercise-price adjustment clause were exercised as follows. For the Thirteenth Series Stock Acquisition Rights, 107,117 rights were exercised, 10,711,700 shares were delivered, the average exercise price was ¥87.9, and proceeds were ¥941 million.」
Exercise of the Thirteenth Series Stock Acquisition Rights progressed, with 10,711,700 shares issued and ¥941 million raised during the quarter. By the filing date, a further 6,521,700 shares had been issued and the financing was continuing. - FY2020AdvancedAnnual report
「Issuance of the Thirteenth Series Stock Acquisition Rights ① Type and number of underlying shares: 33,333,400 common shares ⑤ Amount of funds to be raised: ¥3,029 million」
The company issued the Thirteenth Series Stock Acquisition Rights and planned to raise ¥3,029 million against 33,333,400 common shares. By 19 June 2020, 105,700 rights had been exercised and payment of ¥929 million had also been disclosed. - FY2020-Q3AdvancedAnnual report
「At a Board of Directors meeting held on 21 January 2020, the company resolved to issue the Twelfth Series Stock Acquisition Rights through a third-party allotment. Payment procedures for the issue were completed on 6 February 2020. The underlying securities are 23,952,000 common shares, the amount of funds to be raised is ¥4,039 million, and the exercise period is from 6 February 2020 to 28 February 2022.」
The company resolved on a third-party allotment of the Twelfth Series Stock Acquisition Rights covering 23,952,000 common shares and expected to raise ¥4,039 million; payment was completed on 6 February 2020. - FY2020-Q1AdvancedAnnual report
「The third-party capital increase, with a payment period from 7 June 2019 to 14 June 2019, increased the total number of issued shares by 1,408,400, capital by ¥250 million and the capital reserve by ¥249 million.」
Following the May 2019 resolution concerning the Tenth Series Stock Acquisition Rights and others, the third-party capital increase issued 1,408,400 shares and raised ¥250 million in capital and ¥249 million in the capital reserve. - FY2019AdvancedAnnual report
「At a Board of Directors meeting held on 22 May 2019, the company resolved to issue new shares through a third-party allotment, the Tenth Series Stock Acquisition Rights and stock acquisition rights in the form of stock-based compensation. Payment procedures for the new shares issued through the third-party allotment and the Tenth Series Stock Acquisition Rights were completed on 7 June 2019.」
The company resolved to issue the Tenth Series Stock Acquisition Rights and new shares through a third-party allotment, with payment completed by the filing date. The financing progressed to include 1,408,400 new shares and the Tenth Series Stock Acquisition Rights equivalent to 2,816,900 shares. - FY2019-Q3AdvancedAnnual report
「1 October 2018–31 December 2018 (Note) 1,000 57,057,200 0 3,696 0 3,715 (Note) Increase resulting from the exercise of stock acquisition rights.」
During the third quarter, a further 1,000 shares were issued through the exercise of stock acquisition rights, bringing the total number of issued shares to 57,057,200. - FY2019-Q2AdvancedAnnual report
「1 July 2018–30 September 2018 (Note) 6,000 57,056,200 0 3,695 0 3,715 (Note) Resulting from the exercise of stock acquisition rights.」
During the second quarter, 6,000 shares were issued through the exercise of stock acquisition rights, bringing the total number of issued shares to 57,056,200. - FY2019-Q1AdvancedAnnual report
「1 April 2018–30 June 2018 (Note) 103,100 57,050,200 10 3,695 10 3,714 (Note) Resulting from the exercise of stock acquisition rights.」
In the first quarter, 103,100 shares were issued through the exercise of stock acquisition rights, increasing the total number of issued shares, capital and the capital reserve. - FY2018AdvancedAnnual report
「During the fiscal year, the exercise of stock acquisition rights increased the total number of issued shares by 16,991,500 and increased capital and the capital reserve by ¥3,136.622 million each.」
The exercise of the Eighth and Ninth Series Stock Acquisition Rights and others resulted in the issuance of 16,991,500 shares during the year and a significant increase in capital and the capital reserve. - FY2018-Q3AdvancedAnnual report
「New shares were issued because EVO FUND, the allottee of the Ninth Series Stock Acquisition Rights issued pursuant to the Board resolution of 3 October 2017, and Sea Otter Global Ventures, LLC, a partial transferee, exercised part of those rights. As a result, capital and the capital reserve each increased by ¥1,770.925 million.」
The partial exercise of the Ninth Series Stock Acquisition Rights resulted in the delivery of 5,200,000 shares during the quarter, generating ¥3,541 million in proceeds. - FY2018-Q2AdvancedAnnual report
「At a Board of Directors meeting held on 3 October 2017, the company resolved to issue stock acquisition rights through a third-party allotment to EVO FUND, namely the Ninth Series Stock Acquisition Rights with an exercise-price adjustment clause (the “Stock Acquisition Rights”). All payments for the allocated Stock Acquisition Rights had been completed by the allottee on 19 October 2017. ② Total number of Stock Acquisition Rights: 6,000,000. ⑤ Amount of funds to be raised: ¥6,395,500,000. ⑨ Exercise period: 20 October 2017 to 30 January 2018.」
The company disclosed the third-party allotment of the Ninth Series Stock Acquisition Rights to EVO FUND, the issuance of 6 million rights, completion of payment, planned proceeds of approximately ¥6.396 billion, and an exercise period ending 30 January 2018. - FY2018-Q1AdvancedAnnual report
「In the first quarter, new shares were issued following the partial exercise of the Eighth Series Stock Acquisition Rights by United Asia Hong Kong Group Limited and 株式会社k-style investment partners, the allottees of those rights. As a result, capital and the capital reserve each increased by ¥597.290 million.」
The partial exercise of the Eighth Series Stock Acquisition Rights resulted in the issuance of 5,846,900 shares during the quarter and increased capital and the capital reserve by ¥597.290 million each. The disclosure also states that a further 1,161,000 shares were issued in July. - FY2017AdvancedAnnual report
「1 April 2016–31 March 2017 (Note 2) 700,000 39,955,600 71,508 548,155 71,508 567,653」
During the fiscal year, 700,000 shares were issued through the exercise of stock acquisition rights, increasing the total number of issued shares, capital and the capital reserve. - FY2017-Q2AdvancedAnnual report
「15 July 2016 (Note 1) 1,485,100 39,255,600 149,995 476,647 149,995 496,145. A third-party capital increase with a payment period from 11 July 2016 to 15 July 2016 increased the total number of issued shares by 1,485,100 and increased capital and the capital reserve by ¥149.995 million each. 19 July 2016 (Note 2) 250,000 39,505,600 25,538 502,185 25,538 521,683. The exercise of stock acquisition rights on 19 July 2016 increased the total number of issued shares by 250,000 and increased capital and the capital reserve by ¥25.538 million each.」
Following the issuance and completion of payment for 1,485,100 shares through a third-party allotment, 250,000 shares were issued on 19 July 2016 through the partial exercise of stock acquisition rights, further increasing capital and the capital reserve. - FY2017-Q1First statedAnnual report
「At a Board of Directors meeting held on 23 June 2016, the company resolved to issue new shares and stock acquisition rights through a third-party allotment, including the Eighth Series Stock Acquisition Rights. All payments for the allocated new shares and stock acquisition rights had been completed by the allottees by 13 July 2016.」
The company carried out a third-party capital increase involving 1,485,100 common shares, with total issue proceeds of ¥299,990,200, and issued stock acquisition rights; payment completion was disclosed.